Key result
Prior AF linked to ~167% higher risk of death or HF rehospitalization after MitraClip.
Why the study?
There is uncertainty on the outlook of real-world patients with atrial fibrillation undergoing transcatheter mitral valve repair with MitraClip.
Does a history of atrial fibrillation increase the risk of adverse events in patients undergoing TMVR with MitraClip?
Cohort (n=116)
Yes
Does a history of atrial fibrillation increase the risk of adverse events in patients undergoing TMVR with MitraClip?
In patients undergoing TMVR with MitraClip, a history of atrial fibrillation is associated with a significantly higher risk of death or heart failure rehospitalization.
Answers are grounded in this paper and cite their sources.
AF history may identify higher-risk MitraClip patients for closer surveillance; leaves open whether rhythm interventions improve outcomes.
Background: Atrial Fibrillation (AF) may impact adversely on mitral valve function.Transcatheter Mitral Valve Repair (TMVR) with MitraClip is considered an acceptable alternative to surgical repair in high risk patients, and the EVEREST II trial has suggested that this holds true even in patients with AF.However, there is uncertainty on the outlook of real-world patients with AF undergoing TMVR.Methods: We analyzed retrospectively collected data on patients undergoing TMVR at 3 tertiary care centers.Baseline, procedural, and outcome details were systematically sought.Patients were followed after discharge for clinical events and echocardiographic changes.Results: A total of 116 subjects were included: 61 (53%) with AF and 55 (47%) without AF.Patients with AF had worse baseline functional class and EuroSCORE II, and a higher prevalence of type II mitral regurgitation, but patients without AF had higher prevalence of dilated or ischemic cardiomyopathy and of severe mitral regurgitation (all p < 0.05).Procedural success was achieved in most patients (115 [99%]) with out any differences according to the history of AF, but multiple MitraClips were required more frequently in patients with AF (p = 0.031).Echocardiographic and clinical results at follow-up were also similarly favorable, with 4 (3%) in-hospital deaths and a total of 15 (13%) at follow-up.However, patients with AF had a higher incidence of the composite of death or rehospitalizations for heart failure (14 [34%] vs 5 [13%], p = 0.035).Differences were not especially pronounced when focusing on patients with longstanding/ permanent AF vs those with paroxysmal/persistent AF.Conclusions: Despite largely similar baseline, echocardiographic and procedural features, patients with AF undergoing TMVR with MitraClip may face a higher risk of adverse events during follow-up.Careful follow-up and medical management are thus mandatory in such patients, irrespective of the subtype of AF.
No takes yet. Share an insight, caveat, or question.
Arturo Giordano (2015) conducted a cohort in Significant mitral valve regurgitation (n=116). Atrial fibrillation vs. No atrial fibrillation was evaluated on Composite of death or rehospitalization for heart failure (p=0.035). In patients undergoing transcatheter mitral valve repair with MitraClip, a history of atrial fibrillation was associated with a higher incidence of death or heart failure rehospitalization.
Synapse has enriched 10 related papers. Consider them for comparative context: